Selective reductive cleavage of 2,3-epoxybromides by the InCl3–NaBH4 reagent system
摘要:
A combination of sodium borohydride and a catalytic amount of indium(Ill) chloride in acetonitrile reduces 2,3-epoxy-bromides to the corresponding allylic alcohols in good yields involving reduction of the bromo moiety followed by selective C-O bond cleavage through a radical process. Several aromatic, cyclic and open-chain bromoepoxides successfully participated in this reaction. (C) 2004 Elsevier Ltd. All rights reserved.
Selective reductive cleavage of 2,3-epoxybromides by the InCl3–NaBH4 reagent system
摘要:
A combination of sodium borohydride and a catalytic amount of indium(Ill) chloride in acetonitrile reduces 2,3-epoxy-bromides to the corresponding allylic alcohols in good yields involving reduction of the bromo moiety followed by selective C-O bond cleavage through a radical process. Several aromatic, cyclic and open-chain bromoepoxides successfully participated in this reaction. (C) 2004 Elsevier Ltd. All rights reserved.
The substituent effect at the C6-position of 1,3a,6a-triazapentalenes was elucidated. Synthesis of C6-substituted-1,3a,6a-triazapentalene was established by an epoxide-opening reaction of the 1,2,3-triazoles followed by elimination of the resulting hydroxy group. The electron-donating substituent induced a longer-wavelength shift of the fluorescence maximum and change of the fluorescence quantum yield
Benzimidazo[2,1-b]quinazolin-12(6H)ones, immunosuppressives and agents for treatment of auto-immune diseases, are prepared via (1) reacting a 2-chlorobenzimidazole with an anthranilic acid or ester; (2) reacting a 2-aminobenzimidazole with an anthranilic acid or ester in the presence of trifluoroacetic acid or (3) reacting a 2-methylmercaptobenzimidazole with an anthraniloyl halide hydrohalide.
A process for producing a phenoxycycloalkanol comprising reacting an aromatic alcohol with an (optionally substituted) C.sub.5 -C.sub.6 cycloalk-1,2-ylene oxide in the presence of an effective amount of a sodium-containing catalyst selected from the group consisting of sodium metal, C.sub.1 -C.sub.8 sodium alkoxide, C.sub.6 -C.sub.10 sodium aryloxide, C.sub.7 -C.sub.9 sodium alkaryloxide and sodium hydride at between about 170.degree. C. and about 225.degree. C.
TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS
申请人:Forma Therapeutics, Inc.
公开号:US20150232445A1
公开(公告)日:2015-08-20
The present invention relates to inhibitors of bromo and extra terminal (BET) bromodomains that are useful for the treatment of cancer, inflammatory diseases, diabetes, and obesity, having Formula I:
wherein W, X, Y, Z, R
1
, R
2
, R
5
, and R
8
are as described herein.